812 related articles for article (PubMed ID: 33509277)
41. Isomalto-oligosaccharides, a prebiotic, functionally augment green tea effects against high fat diet-induced metabolic alterations via preventing gut dysbacteriosis in mice.
Singh DP; Singh J; Boparai RK; Zhu J; Mantri S; Khare P; Khardori R; Kondepudi KK; Chopra K; Bishnoi M
Pharmacol Res; 2017 Sep; 123():103-113. PubMed ID: 28668709
[TBL] [Abstract][Full Text] [Related]
42. Supplementation with galacto-oligosaccharides increases the percentage of NK cells and reduces colitis severity in Smad3-deficient mice.
Gopalakrishnan A; Clinthorne JF; Rondini EA; McCaskey SJ; Gurzell EA; Langohr IM; Gardner EM; Fenton JI
J Nutr; 2012 Jul; 142(7):1336-42. PubMed ID: 22496400
[TBL] [Abstract][Full Text] [Related]
43.
Fehlbaum S; Prudence K; Kieboom J; Heerikhuisen M; van den Broek T; Schuren FHJ; Steinert RE; Raederstorff D
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30308944
[TBL] [Abstract][Full Text] [Related]
44. Galacto-oligosaccharides derived from lactulose exert a selective stimulation on the growth of Bifidobacterium animalis in the large intestine of growing rats.
Marín-Manzano MC; Abecia L; Hernández-Hernández O; Sanz ML; Montilla A; Olano A; Rubio LA; Moreno FJ; Clemente A
J Agric Food Chem; 2013 Aug; 61(31):7560-7. PubMed ID: 23855738
[TBL] [Abstract][Full Text] [Related]
45. Prebiotic Oligosaccharides: Comparative Evaluation Using In Vitro Cultures of Infants' Fecal Microbiomes.
Stiverson J; Williams T; Chen J; Adams S; Hustead D; Price P; Guerrieri J; Deacon J; Yu Z
Appl Environ Microbiol; 2014 Dec; 80(23):7388-97. PubMed ID: 25239906
[TBL] [Abstract][Full Text] [Related]
46. Consumption of non-digestible oligosaccharides elevates colonic alkaline phosphatase activity by up-regulating the expression of IAP-I, with increased mucins and microbial fermentation in rats fed a high-fat diet.
Okazaki Y; Katayama T
Br J Nutr; 2019 Jan; 121(2):146-154. PubMed ID: 30400998
[TBL] [Abstract][Full Text] [Related]
47. Galacto-oligosaccharides supplementation in prefrail older and healthy adults increased faecal bifidobacteria, but did not impact immune function and oxidative stress.
Wilms E; An R; Smolinska A; Stevens Y; Weseler AR; Elizalde M; Drittij MJ; Ioannou A; van Schooten FJ; Smidt H; Masclee AAM; Zoetendal EG; Jonkers DMAE
Clin Nutr; 2021 May; 40(5):3019-3031. PubMed ID: 33509667
[TBL] [Abstract][Full Text] [Related]
48. Supplementation of diet with non-digestible oligosaccharides alters the intestinal microbiota, but not arthritis development, in IL-1 receptor antagonist deficient mice.
Rogier R; Ederveen THA; Wopereis H; Hartog A; Boekhorst J; van Hijum SAFT; Knol J; Garssen J; Walgreen B; Helsen MM; van der Kraan PM; van Lent PLEM; van de Loo FAJ; Abdollahi-Roodsaz S; Koenders MI
PLoS One; 2019; 14(7):e0219366. PubMed ID: 31283798
[TBL] [Abstract][Full Text] [Related]
49. In Vivo Healthy Benefits of Galacto-Oligosaccharides from
Godínez-Méndez LA; Gurrola-Díaz CM; Zepeda-Nuño JS; Vega-Magaña N; Lopez-Roa RI; Íñiguez-Gutiérrez L; García-López PM; Fafutis-Morris M; Delgado-Rizo V
Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827656
[TBL] [Abstract][Full Text] [Related]
50. Fructooligosaccharides and galactooligosaccharides improve hepatic steatosis via gut microbiota-brain axis modulation.
Silva RSD; Mendonça IP; Paiva IHR; Souza JRB; Peixoto CA
Int J Food Sci Nutr; 2023 Nov; 74(7):760-780. PubMed ID: 37771001
[TBL] [Abstract][Full Text] [Related]
51. Antioxidant Vitamins and Prebiotic FOS and XOS Differentially Shift Microbiota Composition and Function and Improve Intestinal Epithelial Barrier In Vitro.
Pham VT; Calatayud M; Rotsaert C; Seifert N; Richard N; Van den Abbeele P; Marzorati M; Steinert RE
Nutrients; 2021 Mar; 13(4):. PubMed ID: 33805552
[TBL] [Abstract][Full Text] [Related]
52. A Polysaccharide Isolated from Dictyophora indusiata Promotes Recovery from Antibiotic-Driven Intestinal Dysbiosis and Improves Gut Epithelial Barrier Function in a Mouse Model.
Kanwal S; Joseph TP; Owusu L; Xiaomeng R; Meiqi L; Yi X
Nutrients; 2018 Jul; 10(8):. PubMed ID: 30065236
[TBL] [Abstract][Full Text] [Related]
53. Prebiotics for Lactose Intolerance: Variability in Galacto-Oligosaccharide Utilization by Intestinal
Arnold JW; Simpson JB; Roach J; Bruno-Barcena JM; Azcarate-Peril MA
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30332787
[TBL] [Abstract][Full Text] [Related]
54. Galacto-oligosaccharides as infant prebiotics: production, application, bioactive activities and future perspectives.
Ambrogi V; Bottacini F; Cao L; Kuipers B; Schoterman M; van Sinderen D
Crit Rev Food Sci Nutr; 2023; 63(6):753-766. PubMed ID: 34477457
[TBL] [Abstract][Full Text] [Related]
55. Enzymatically synthesized α-galactooligosaccharides attenuate metabolic syndrome in high-fat diet induced mice in association with the modulation of gut microbiota.
He N; Chen H; Zhou Z; Zhao W; Wang S; Lv Z; Liu N; Wang H; Yang Z; Li S
Food Funct; 2021 Jun; 12(11):4960-4971. PubMed ID: 34100482
[TBL] [Abstract][Full Text] [Related]
56. Prenatal caprine milk oligosaccharide consumption affects the development of mice offspring.
Thum C; McNabb WC; Young W; Cookson AL; Roy NC
Mol Nutr Food Res; 2016 Sep; 60(9):2076-85. PubMed ID: 27067267
[TBL] [Abstract][Full Text] [Related]
57. Impact of galacto-oligosaccharides on the gut microbiota composition and metabolic activity upon antibiotic treatment during in vitro fermentation.
Ladirat SE; Schuren FH; Schoterman MH; Nauta A; Gruppen H; Schols HA
FEMS Microbiol Ecol; 2014 Jan; 87(1):41-51. PubMed ID: 23909489
[TBL] [Abstract][Full Text] [Related]
58. Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders.
Wilson B; Whelan K
J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():64-68. PubMed ID: 28244671
[TBL] [Abstract][Full Text] [Related]
59. A double-blind, 377-subject randomized study identifies
Azcarate-Peril MA; Roach J; Marsh A; Chey WD; Sandborn WJ; Ritter AJ; Savaiano DA; Klaenhammer TR
Gut Microbes; 2021; 13(1):1957536. PubMed ID: 34365905
[No Abstract] [Full Text] [Related]
60. New prebiotic blend of polydextrose and galacto-oligosaccharides has a bifidogenic effect in young infants.
Scalabrin DM; Mitmesser SH; Welling GW; Harris CL; Marunycz JD; Walker DC; Bos NA; Tölkkö S; Salminen S; Vanderhoof JA
J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):343-52. PubMed ID: 21946836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
